CAT.INIST
Accueil du sitewww.cnrs.frwww.inist.frOther CNRS


COMMANDER / ORDER
PARTAGER / SHARE
EXPORT
Bookmark and Share
Mendeley    EndNote

Titre du document / Document title

Bioequivalence study of generic acyclovir compared with the brand name Acyclovir®

Auteur(s) / Author(s)

ROJANASTHIEN Noppamas (1) ; KUMSORN Boonyium (1) ; YUEN KAH HAY (2) ; TEEKACHUNHATEAN Supanimit (1) ; CHAICHANA Nuchanart (1) ;

Affiliation(s) du ou des auteurs / Author(s) Affiliation(s)

(1) Division of Clinical Pharmacology, Department of Pharmacology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, THAILANDE
(2) School of Pharmaceutical Sciences, University of Science Malaysia, 11800 Minden, Penang, MALAISIE

Résumé / Abstract

The bioequivalence study of 200-mg generic acyclovir was conducted in healthy males. The reference Zovirax® and the test Zevin® were administered as a single oral dose after an overnight fast in a two-period, crossover design separated by 1 week. Serial blood samples were collected over a period of 24 hours. Plasma acyclovir concentrations were determined by HPLC and the pharmacokinetic parameters were analyzed by non-compartmental analysis. Results: The t1/2 for the test (4.5 ± 2.4 h) and Zovirax® (3.9 ± 2.6 h) were comparable. The analysis of variance was carried out and the median Tmax (1.50 h) for the test was not statistically difference from Zovirax®. The mean (90% CI) of the AUC0-∞ and the Cmax ratios for (Test/Reference) were 0.95 (0.83 - 1.09) and 0.95 (0.83 - 1.10), respectively. These values fell within the bioequivalence criteria of 0.80 - 1.25, thus it was concluded that Zevin® and Zovirax® were bioequivalence.

Revue / Journal Title

Chot Mai Het Thang Phaet   ISSN 0125-2208   CODEN JMTHBU 

Source / Source

2002, vol. 85, no10, pp. 1121-1129 [9 page(s) (article)] (14 ref.)

Langue / Language

Anglais

Editeur / Publisher

Medical Association of Thailand, Bangkok, THAILANDE  (1919) (Revue)

Mots-clés anglais / English Keywords

Purine nucleoside ; Acyclic nucleoside ; Bioavailability ; Concentration ; High performance ; Liquid chromatography ; Generic drug ; Bioequivalence ; Pharmacokinetics ; Pharmacology ; Experimental study ; Volunteer ; Human ; Antiviral ; Aciclovir ;

Mots-clés français / French Keywords

Purine nucléoside ; Nucléoside acyclique ; Biodisponibilité ; Concentration ; Haute performance ; Chromatographie phase liquide ; Médicament générique ; Bioéquivalence ; Pharmacocinétique ; Pharmacologie ; Etude expérimentale ; Volontaire ; Homme ; Antiviral ; Aciclovir ;

Mots-clés espagnols / Spanish Keywords

Purina nucleósido ; Nucleósido acíclico ; Biodisponibilidad ; Concentración ; Alto rendimiento ; Cromatografía fase líquida ; Medicamento genérico ; Bioequivalencia ; Farmacocinética ; Farmacología ; Estudio experimental ; Voluntario ; Hombre ; Antiviral ; Aciclovir ;

Localisation / Location

INIST-CNRS, Cote INIST : 17480, 35400010572163.0120

Nº notice refdoc (ud4) : 14453990

COMMANDER / ORDER
PARTAGER / SHARE
EXPORT
Bookmark and Share
Mendeley    EndNote

CAT.INIST